Annual Operating Expenses
$52.36 M
+$9.75 M+22.90%
31 December 2023
Summary:
Aptose Biosciences annual total operating expenses is currently $52.36 million, with the most recent change of +$9.75 million (+22.90%) on 31 December 2023. During the last 3 years, it has fallen by -$3.41 million (-6.12%). APTO annual operating expenses is now -20.00% below its all-time high of $65.45 million, reached on 31 December 2021.APTO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$6.96 M
-$380.00 K-5.17%
30 September 2024
Summary:
Aptose Biosciences quarterly total operating expenses is currently $6.96 million, with the most recent change of -$380.00 thousand (-5.17%) on 30 September 2024. Over the past year, it has dropped by -$4.72 million (-40.37%). APTO quarterly operating expenses is now -71.39% below its all-time high of $24.35 million, reached on 31 December 2021.APTO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.9% | -40.4% |
| 3 y3 years | -6.1% | -38.7% |
| 5 y5 years | +79.9% | -0.9% |
APTO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.0% | +22.9% | -71.4% | at low |
| 5 y | 5 years | -20.0% | +94.9% | -71.4% | at low |
| alltime | all time | -20.0% | +502.7% | -71.4% | +258.9% |
Aptose Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.96 M(-5.2%) |
| June 2024 | - | $7.34 M(-24.7%) |
| Mar 2024 | - | $9.76 M(-19.5%) |
| Dec 2023 | $52.36 M(+22.9%) | $12.13 M(+3.8%) |
| Sept 2023 | - | $11.68 M(-19.2%) |
| June 2023 | - | $14.45 M(+2.5%) |
| Mar 2023 | - | $14.10 M(+35.5%) |
| Dec 2022 | $42.60 M(-34.9%) | $10.40 M(+3.8%) |
| Sept 2022 | - | $10.03 M(-6.1%) |
| June 2022 | - | $10.67 M(-7.2%) |
| Mar 2022 | - | $11.50 M(-52.8%) |
| Dec 2021 | $65.45 M(+17.4%) | $24.35 M(+114.3%) |
| Sept 2021 | - | $11.36 M(-15.8%) |
| June 2021 | - | $13.49 M(-17.0%) |
| Mar 2021 | - | $16.25 M(+10.1%) |
| Dec 2020 | $55.77 M(+107.6%) | $14.76 M(+11.0%) |
| Sept 2020 | - | $13.29 M(-16.3%) |
| June 2020 | - | $15.88 M(+34.2%) |
| Mar 2020 | - | $11.83 M(+50.1%) |
| Dec 2019 | $26.86 M(-7.7%) | $7.88 M(+12.2%) |
| Sept 2019 | - | $7.03 M(+10.7%) |
| June 2019 | - | $6.35 M(+13.3%) |
| Mar 2019 | - | $5.60 M(-11.5%) |
| Dec 2018 | $29.11 M(+146.1%) | $6.33 M(+12.7%) |
| Sept 2018 | - | $5.61 M(-45.7%) |
| June 2018 | - | $10.33 M(+51.0%) |
| Mar 2018 | - | $6.84 M(+106.6%) |
| Dec 2017 | $11.83 M(-17.1%) | $3.31 M(+22.2%) |
| Sept 2017 | - | $2.71 M(+9.2%) |
| June 2017 | - | $2.48 M(-25.4%) |
| Mar 2017 | - | $3.33 M(+6.4%) |
| Dec 2016 | $14.27 M(+11.0%) | $3.13 M(+0.4%) |
| Sept 2016 | - | $3.12 M(-28.5%) |
| June 2016 | - | $4.36 M(+14.9%) |
| Mar 2016 | - | $3.79 M(-13.2%) |
| Dec 2015 | $12.86 M(+87.8%) | $4.37 M(+47.7%) |
| Sept 2015 | - | $2.96 M(-3.7%) |
| June 2015 | - | $3.07 M(+6.6%) |
| Mar 2015 | - | $2.88 M(-9.2%) |
| Dec 2014 | $6.84 M(-22.4%) | - |
| May 2014 | $8.82 M(+62.6%) | $3.17 M(+49.1%) |
| Feb 2014 | - | $2.13 M(-17.2%) |
| Nov 2013 | - | $2.57 M(+154.2%) |
| Aug 2013 | - | $1.01 M(-19.3%) |
| May 2013 | $5.42 M(+21.5%) | $1.25 M(-7.1%) |
| Feb 2013 | - | $1.35 M(-17.5%) |
| Nov 2012 | - | $1.63 M(+28.6%) |
| Aug 2012 | - | $1.27 M(+51.6%) |
| May 2012 | $4.46 M(-11.7%) | $839.00 K(-18.4%) |
| Feb 2012 | - | $1.03 M(-27.2%) |
| Nov 2011 | - | $1.41 M(+23.3%) |
| Aug 2011 | - | $1.15 M(+3.0%) |
| May 2011 | $5.05 M | $1.11 M(-29.7%) |
| Feb 2011 | - | $1.58 M(+37.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2010 | - | $1.15 M(+8.1%) |
| Aug 2010 | - | $1.07 M(-41.6%) |
| May 2010 | $5.52 M(-18.2%) | $1.83 M(+42.4%) |
| Feb 2010 | - | $1.28 M(+1.7%) |
| Nov 2009 | - | $1.26 M(+15.2%) |
| Aug 2009 | - | $1.09 M(-46.0%) |
| May 2009 | $6.74 M(-39.1%) | $2.03 M(+26.8%) |
| Feb 2009 | - | $1.60 M(+10.3%) |
| Nov 2008 | - | $1.45 M(-28.4%) |
| Aug 2008 | - | $2.03 M(-36.6%) |
| May 2008 | $11.07 M(+43.6%) | $3.20 M(-7.4%) |
| Feb 2008 | - | $3.45 M(+29.2%) |
| Nov 2007 | - | $2.67 M(+63.0%) |
| Aug 2007 | - | $1.64 M(-9.8%) |
| May 2007 | $7.71 M(-49.0%) | $1.82 M(+22.5%) |
| Feb 2007 | - | $1.48 M(-39.7%) |
| Nov 2006 | - | $2.46 M(+15.3%) |
| Aug 2006 | - | $2.13 M(-22.8%) |
| May 2006 | $15.11 M(-13.3%) | $2.76 M(-16.3%) |
| Feb 2006 | - | $3.30 M(-19.9%) |
| Nov 2005 | - | $4.12 M(-10.6%) |
| Aug 2005 | - | $4.61 M(+43.5%) |
| May 2005 | $17.42 M(-26.1%) | $3.21 M(-23.2%) |
| Feb 2005 | - | $4.18 M(-17.0%) |
| Nov 2004 | - | $5.04 M(+3.5%) |
| Aug 2004 | - | $4.87 M(-13.9%) |
| May 2004 | $23.58 M(-281.3%) | $5.65 M(-10.8%) |
| Feb 2004 | - | $6.34 M(+19.9%) |
| Nov 2003 | - | $5.29 M(-14.9%) |
| Aug 2003 | - | $6.21 M(-241.7%) |
| May 2003 | -$13.00 M(-228.3%) | -$4.38 M(+60.1%) |
| Feb 2003 | - | -$2.74 M(-200.0%) |
| Nov 2002 | - | $2.74 M(-4.1%) |
| Aug 2002 | - | $2.85 M(-4.6%) |
| May 2002 | $10.13 M(-21.8%) | $2.99 M(+35.5%) |
| Feb 2002 | - | $2.21 M(-18.1%) |
| Nov 2001 | - | $2.70 M(+14.2%) |
| Aug 2001 | - | $2.36 M(-50.1%) |
| May 2001 | $12.95 M(+83.8%) | $4.74 M(+88.5%) |
| Feb 2001 | - | $2.51 M(-23.5%) |
| Nov 2000 | - | $3.28 M(+29.9%) |
| Aug 2000 | - | $2.53 M(-39.1%) |
| May 2000 | $7.05 M(+99.8%) | $4.15 M(+173.9%) |
| Feb 2000 | - | $1.52 M(+86.0%) |
| Nov 1999 | - | $814.90 K(+74.0%) |
| Aug 1999 | - | $468.40 K(-46.5%) |
| May 1999 | $3.53 M(+0.7%) | $875.00 K(+1.5%) |
| Feb 1999 | - | $861.80 K(+20.3%) |
| Nov 1998 | - | $716.10 K(-24.5%) |
| Aug 1998 | - | $949.10 K(-2.3%) |
| May 1998 | $3.50 M(-1.5%) | $971.80 K(+15.3%) |
| Feb 1998 | - | $843.20 K(-0.0%) |
| Nov 1997 | - | $843.30 K(+6.5%) |
| Aug 1997 | - | $791.90 K |
| May 1997 | $3.56 M | - |
FAQ
- What is Aptose Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Aptose Biosciences?
- What is Aptose Biosciences annual operating expenses year-on-year change?
- What is Aptose Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aptose Biosciences?
- What is Aptose Biosciences quarterly operating expenses year-on-year change?
What is Aptose Biosciences annual total operating expenses?
The current annual operating expenses of APTO is $52.36 M
What is the all time high annual operating expenses for Aptose Biosciences?
Aptose Biosciences all-time high annual total operating expenses is $65.45 M
What is Aptose Biosciences annual operating expenses year-on-year change?
Over the past year, APTO annual total operating expenses has changed by +$9.75 M (+22.90%)
What is Aptose Biosciences quarterly total operating expenses?
The current quarterly operating expenses of APTO is $6.96 M
What is the all time high quarterly operating expenses for Aptose Biosciences?
Aptose Biosciences all-time high quarterly total operating expenses is $24.35 M
What is Aptose Biosciences quarterly operating expenses year-on-year change?
Over the past year, APTO quarterly total operating expenses has changed by -$4.72 M (-40.37%)